The <scp>COVID</scp>‐19 pandemic as a modifier of <scp>DGBI</scp> symptom severity: A systematic review and meta‐analysis
Dmitrii Kulin(Translational Research Institute), Gerald Holtmann(Royal Adelaide Hospital), Ayesha Shah(Translational Research Institute), Uday C. Ghoshal(Sanjay Gandhi Post Graduate Institute of Medical Sciences), Nicholas J. Talley(University of Newcastle Australia), Yeong Yeh Lee(Hospital Universiti Sains Malaysia), Purna Kashyap(Mayo Clinic), Michael Jones(Macquarie University), Thomas Fairlie(Translational Research Institute), Agata Mulak(Wroclaw Medical University), Xiucai Fang(Chinese Academy of Medical Sciences & Peking Union Medical College), Reuben K. Wong(National University of Singapore), Natasha A. Koloski(Princess Alexandra Hospital)
Cited by 2
Related Papers
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study
|Gastroenterology|2020|2.1k
Gut microbes promote colonic serotonin production through an effect of short‐chain fatty acids on enterochromaffin cells
|The FASEB Journal|2014|1.3k
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
|Nature|2013|1.1k
US Immigration Westernizes the Human Gut Microbiome
|Cell|2018|850